ArticleMolecular pharmaceutics2013
Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.
Article in Molecular pharmaceutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Double-Emulsion Perfluorocarbon Nanodroplets for Ultrasound and Photoacoustic Image-Guided Drug Delivery and Release.ACS nano · 2025Article
- Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines.NPJ vaccines · 2024Article
- The phospholipid membrane compositions of bacterial cells, cancer cell lines and biological samples from cancer patients.Chemical science · 2021Review
- Neurochips: Considerations from a neurosurgeon's standpoint.Surgical neurology international · 2021Article
- Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.Molecular pharmaceutics · 2020Article
- Protein-loaded soluble and nanoparticulate formulations of ionic polyphosphazenes and their interactions on molecular and cellular levels.Materials science & engineering. C, Materials for biological applications · 2020Article
- Magnetically targeted nanoparticles for imaging-guided photothermal therapy of cancer.RSC advances · 2019Article
- Biomimetic delivery of signals for bone tissue engineering.Bone research · 2018Article
- Biodegradable "Smart" Polyphosphazenes with Intrinsic Multifunctionality as Intracellular Protein Delivery Vehicles.Biomacromolecules · 2017Article
- Preprogrammed Long-Term Systemic Pulsatile Delivery of Parathyroid Hormone to Strengthen Bone.Advanced healthcare materials · 2017Article
- Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.Theranostics · 2017Review
- Supramolecular PEGylation of biopharmaceuticals.Proceedings of the National Academy of Sciences of the United States of America · 2016Article
- Development of peptide inhibitors of HIV transmission.Bioactive materials · 2016Review
- Engineering responsive supramolecular biomaterials: Toward smart therapeutics.Bioengineering & translational medicine · 2016Review
- Review
- A perspective on the clinical translation of scaffolds for tissue engineering.Annals of biomedical engineering · 2015Article
- Polyethylene-oxide improves microcirculatory blood flow in a murine hemorrhagic shock model.International journal of clinical and experimental medicine · 2015Article
- Smart approaches to glucose-responsive drug delivery.Journal of drug targeting · 2015Review
- Cell or cell membrane-based drug delivery systems.Theranostics · 2015Review
- Bionanotechnology and the future of glioma.Surgical neurology international · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Early science fiction envisioned the future of drug delivery as targeted micrometer-scale submarines and "cyborg" body parts. Here we describe the progression of the field toward technologies that are now beginning to capture aspects of this early vision. Specifically, we focus on the two most prominent types of systems in drug delivery: the intravascular micro/nano drug carriers for delivery to the site of pathology and drug-loaded implantable devices that facilitate release with the predefined kinetics or in response to a specific cue. We discuss the unmet clinical needs that inspire these designs, the physiological factors that pose difficult challenges for their realization, and viable technologies that promise robust solutions. We also offer a perspective on where drug delivery may be in the next 50 years based on expected advances in material engineering and in the context of future diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.